HuagongsheHuagongshe Chemistry Print Report · For research reference only
N-alpha-t-Butyloxycarbonyl-S-(4-methyl-benzyl)-L-cysteine → (2S)-6-[[(2R)-2-(tert-butoxycarbonylamino)-3-(p-tolylmethylsulfanyl)propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | N-alpha-t-Butyloxycarbonyl-S-(4-methyl-benzyl)-L-cysteine | HCID 7010551 | — |
| Reactant | Nalpha-isobutyl-Nalpha-(4-ethylbenzenesulfonyl)-L-ysine | HCID 69929831 | — |
| Product | (2S)-6-[[(2R)-2-(tert-butoxycarbonylamino)-3-(p-tolylmethylsulfanyl)propanoyl]amino]-2-[isobutyl(p-tolylsulfonyl)amino]hexanoic acid | HCID 508604 | — |
Reaction Steps
The title compound was prepared from Nα-isobutyl-Nα-(4-ethylbenzenesulfonyl)-L-ysine (100 mg, 0.29 mmol, example 1, step E) as described in general procedure Bc using commercially available Nα-tert-butoxycarbonyl-S-(4-methylbenzyl)-L-cysteine (67 mg, 0.3 mmol). The final product was triturated with ether to yield 130 mg (65%) of the desired material.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06656965B2 |
| Source dataset | uspto-grants-2003_12 |
| ORD ID | ord-3c5995ee499746b8bb319452d26904ee |
| Source note | uspto-grants-2003_12 |